Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer
Bryan P. Schneider(Shanghai University of Traditional Chinese Medicine), Joseph A. Sparano(Tisch Cancer Institute), Fengmin Zhao(Dana-Farber Cancer Institute), Nancy E. Davidson(WinnMed), Vered Stearns(Johns Hopkins University), Vicky Jones(Eastern Cooperative Oncology Group), Edith A. Perez(Unknown), George W. Sledge(Caris Life Sciences (United States)), Molin Wang(Cancer Research And Biostatistics), William C. Wood(Eastern Cooperative Oncology Group), Tom Saphner(University of Wisconsin–Green Bay), Silvana Martino(Angeles Clinic and Research Institute), Antonio C. Wolff(Johns Hopkins University)
Cited by 99
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Alternative Dietary Indices Both Strongly Predict Risk of Chronic Disease
|Journal of Nutrition|2012|1.9k